Evidence map›Paper›PMID 28512560›Full record

ArticleMediterranean journal of hematology and infectious diseases2017

The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach.

Ignazio Majolino, Dosti Othman, Attilio Rovelli, Dastan Hassan, Luqman Rasool, Michele Vacca, Nigar Abdalrahman, Chra Abdullah, Zhalla Ahmed, Dlir Ali and 37 more

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Current status of beta-thalassemia and its treatment strategies.Molecular genetics & genomic medicine · 2021
    Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Ignazio MajolinoInstitute for University Cooperation (ICU), Rome Italy.
Dosti OthmanHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Attilio RovelliInstitute for University Cooperation (ICU), Rome Italy.
Dastan HassanHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Luqman RasoolHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Michele VaccaInstitute for University Cooperation (ICU), Rome Italy.
Nigar AbdalrahmanHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Chra AbdullahHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Zhalla AhmedHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Dlir AliHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Kosar AliHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Chiara BroggiInstitute for University Cooperation (ICU), Rome Italy.
Cinzia CalabrettaInstitute for University Cooperation (ICU), Rome Italy.
Marta CanesiInstitute for University Cooperation (ICU), Rome Italy.
Gloria CiabattiInstitute for University Cooperation (ICU), Rome Italy.
Claudia Del FanteInstitute for University Cooperation (ICU), Rome Italy.
Elisabetta De SapioInstitute for University Cooperation (ICU), Rome Italy.
Giovanna DoreInstitute for University Cooperation (ICU), Rome Italy.
Andrea FrigatoInstitute for University Cooperation (ICU), Rome Italy.
Marcela GabrielInstitute for University Cooperation (ICU), Rome Italy.
Francesco IpsevichInstitute for University Cooperation (ICU), Rome Italy.
Harem KareemHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Dana KarimHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Rosa LeoneInstitute for University Cooperation (ICU), Rome Italy.
Tavan MahmoodHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Annunziata MannaInstitute for University Cooperation (ICU), Rome Italy.
Maria Speranza MasseiInstitute for University Cooperation (ICU), Rome Italy.
Andrea MastriaInstitute for University Cooperation (ICU), Rome Italy.
Dereen MohammedHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Rebar MohammedHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Khoshnaw NajmaddinHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Diana NooriHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Angelo OstuniInstitute for University Cooperation (ICU), Rome Italy.
Angelo PalmasInstitute for University Cooperation (ICU), Rome Italy.
Marco PossentiInstitute for University Cooperation (ICU), Rome Italy.
Ali QadirHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Giorgio RealInstitute for University Cooperation (ICU), Rome Italy.
Rebwar ShrifHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Caterina ValdattaInstitute for University Cooperation (ICU), Rome Italy.
Stefania VastaInstitute for University Cooperation (ICU), Rome Italy.
Marta VernaInstitute for University Cooperation (ICU), Rome Italy.
Mariangela VittoriInstitute for University Cooperation (ICU), Rome Italy.
Awder YousifHiwa Cancer Hospital (HCH), Sulaymaniyah, Iraqi Kurdistan.
Francesco ZallioInstitute for University Cooperation (ICU), Rome Italy.
Alessandro CalistiInstitute for University Cooperation (ICU), Rome Italy.
Sergio QuattrocchiItalian Agency for Development Cooperation (AICS), Rome, Italy.
Corrado GirmeniaInstitute for University Cooperation (ICU), Rome Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the entire process leading to the start-up of a hematopoietic stem cell transplantation center at the Hiwa Cancer Hospital, in the city of Sulaymaniyah, Kurdistan Iraqi Region. This capacity building project was funded by the Italian Development Cooperation Agency and implemented with the support of the volunteer work of Italian professionals, either physicians, nurses, biologists and technicians. The intervention started in April 2016, was based exclusively on training and coaching on site, that represent a significant innovative approach, and led to a first autologous transplant in June 2016 and to the first allogeneic transplant in October. At the time of reporting, 9 months from the initiation of the project, 18 patients have been transplanted, 15 with an autologous and 3 with an allogeneic graft. The center at the HCH represents the first transplantation center in Kurdistan and the second in wide Iraq. We conclude that international development cooperation may play an important role also in the field of high-technology medicine, and contribute to improved local centers capabilities through country to country scientific exchanges. The methodology to realize this project is innovative, since HSCT experts are brought as volunteers to the center(s) to be started, while traditionally it is the opposite, i.e. the local professionals to be trained are brought to the specialized center(s).

Indexed as

bone marrow transplantationcapacity buildingglobal healthKurdistan

Identifiers

PMID28512560
PMCPMC5419198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.